ICI-47699 |
ICI-46474 |
SOLTAMOX |
NOLVADEX |
TAMOXIFEN |
TAMOXIFÈNE |
1-P-BETA-DIMETHYLAMINOETHOXYPHENYL-TRANS-1,2-DIPHENYLBUT-1-ENE |
TRANS-TAMOXIFEN |
1-PARA-BETA-DIMETHYLAMINOETHOXYPHENYL-TRANS-1,2-DIPHENYLBUT-1-ENE |
(Z)-2-(4-(1,2-DIPHENYL-1-BUTENYL)PHENOXY)-N,N-DIMETHYLETHANAMINE |
TAMOXIFENO |
(Z)-2-(PARA-(1,2-DIPHENYL-1-BUTENYL)PHENOXY)-N,N-DIMETHYLAMINE |
TAMOXIFENUM |
NOLVADEX® |
SOLTAMOX® |
ZD6157 |
TAMOXIFENE |
drugbank:00675 |
rxcui:10324 |
chembl:CHEMBL83 |
chemidplus:10540-29-1 |
pubchem.compound:2733526 |
Drug Class | antineoplastic agents, hormonal |
Year of Approval | 1977 |
FDA Approval | 1977 |
Drug Class | small molecule |
Drug Indications | Antineoplastic Agents, Hormonal |
Drug Categories | stilbenes |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp1a2 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2a6 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2b6 inhibitors (moderate) |
Drug Categories | cytochrome p-450 cyp2b6 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2c19 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2c9 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2c9 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2d6 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp2e1 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inducers |
Drug Categories | cytochrome p-450 cyp3a4 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a5 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | estrogen agonist/antagonist |
Drug Categories | narrow therapeutic index drugs |
Drug Categories | p-glycoprotein inducers |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | potential qtc-prolonging agents |
Drug Categories | qtc prolonging agents |
Drug Categories | thyroxine-binding globulin inducers |
Drug Categories | ugt2b7 substrates |
Drug Categories | ugt2b7 substrates with narrow therapeutic index |
agonist (activating) |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Specific Action of the Ligand | Agonist |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
agonist (activating) |
antagonist (inhibitory) |
Alteration | ESR1:E380Q,.537.,.538.,L536.,P535H |
Drug family | Hormonal therapy |
combination therapy | [Tamoxifen,Letrozole,Anastrozole,Exemestane,Fulvestrant,LHRH analogues or antagonist] |
n/a |
n/a |
Alteration | NF1:. |
Alteration | NF1:del |
Drug family | Hormonal therapy |
TAMOXIFEN | DrugBank Drug Name |
10540-29-1 | CAS Number |
Adifen | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | anti-estrogens |
TAMOXIFEN | Primary Drug Name |
Year of Approval | 1977 |
Drug Class | antineoplastic agents, hormonal |
Drug Indications | Antineoplastic Agents, Hormonal |
Drug Class | small molecule |
FDA Approval | 1977 |
C855 | NCI drug code |
CHEMBL83 | ChEMBL Drug ID |
TAMOXIFEN | GuideToPharmacology Ligand Name |
D07KSG | TTD Drug ID |